| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Neuropathology Laboratory,*
Institute of
Pathology, University of Basel, and Novartis Pharma,
Inc.,
Nervous System Research,
Basel, Switzerland
Microglia are a key component of the inflammatory response in the brain and are associated with senile plaques in Alzheimer's disease (AD). Although there is evidence that microglial activation is important for the pathogenesis of AD, the role of microglia in cerebral amyloidosis remains obscure. The present study was undertaken to investigate the relationship between ß-amyloid deposition and microglia activation in APP23 transgenic mice which express human mutated amyloid-ß precursor protein (ßPP) under the control of a neuron-specific promoter element. Light microscopic analysis revealed that the majority of the amyloid plaques in neocortex and hippocampus of 14- to 18- month-old APP23 mice are congophilic and associated with clusters of hypertrophic microglia with intensely stained Mac-1- and phosphotyrosine-positive processes. No association of such activated microglia was observed with diffuse plaques. In young APP23 mice, early amyloid deposits were already of dense core nature and were associated with a strong microglial response. Ultrastructurally, bundles of amyloid fibrils, sometimes surrounded by an incomplete membrane, were observed within the microglial cytoplasm. However, microglia with the typical characteristics of phagocytosis were associated more frequently with dystrophic neurites than with amyloid fibrils. Although the present observations cannot unequivocally determine whether microglia are causal, contributory, or consequential to cerebral amyloidosis, our results suggest that microglia are involved in cerebral amyloidosis either by participating in the processing of neuron-derived ßPP into amyloid fibrils and/or by ingesting amyloid fibrils via an uncommon phagocytotic mechanism. In any case, our observations demonstrate that neuron-derived ßPP is sufficient to induce not only amyloid plaque formation but also amyloid-associated microglial activation similar to that reported in AD. Moreover, our results are consistent with the idea that microglia activation may be important for the amyloid-associated neuron loss previously reported in these mice.
This article has been cited by other articles:
 |
|
 |
|
  B. M. Wegenast-Braun, A. Fulgencio Maisch, D. Eicke, R. Radde, M. C. Herzig, M. Staufenbiel, M. Jucker, and M. E. Calhoun Independent Effects of Intra- and Extracellular A{beta} on Learning-Related Gene Expression Am. J. Pathol., July 1, 2009; 175(1): 271 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ding, A. Qiao, Z. Wang, J. S. Goodwin, E.-S. Lee, M. L. Block, M. Allsbrook, M. P. McDonald, and G.-H. Fan Retinoic Acid Attenuates {beta}-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model J. Neurosci., November 5, 2008; 28(45): 11622 - 11634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Hickman, E. K. Allison, and J. El Khoury Microglial Dysfunction and Defective {beta}-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice J. Neurosci., August 13, 2008; 28(33): 8354 - 8360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. V. Ermini, S. Grathwohl, R. Radde, M. Yamaguchi, M. Staufenbiel, T. D. Palmer, and M. Jucker Neurogenesis and Alterations of Neural Stem Cells in Mouse Models of Cerebral Amyloidosis Am. J. Pathol., June 1, 2008; 172(6): 1520 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bolmont, F. Haiss, D. Eicke, R. Radde, C. A. Mathis, W. E. Klunk, S. Kohsaka, M. Jucker, and M. E. Calhoun Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance J. Neurosci., April 16, 2008; 28(16): 4283 - 4292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bolmont, F. Clavaguera, M. Meyer-Luehmann, M. C. Herzig, R. Radde, M. Staufenbiel, J. Lewis, M. Hutton, M. Tolnay, and M. Jucker Induction of Tau Pathology by Intracerebral Infusion of Amyloid- -Containing Brain Extract and by Amyloid- Deposition in APP x Tau Transgenic Mice Am. J. Pathol., December 1, 2007; 171(6): 2012 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Mori, T. Town, J. Tan, N. Yada, Y. Horikoshi, J. Yamamoto, T. Shimoda, Y. Kamanaka, N. Tateishi, and T. Asano Arundic Acid Ameliorates Cerebral Amyloidosis and Gliosis in Alzheimer Transgenic Mice J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 571 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vegeto, S. Belcredito, S. Ghisletti, C. Meda, S. Etteri, and A. Maggi The Endogenous Estrogen Status Regulates Microglia Reactivity in Animal Models of Neuroinflammation Endocrinology, May 1, 2006; 147(5): 2263 - 2272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Qin, C. Colin, I. Hinners, A. Gervais, C. Cheret, and M. Mallat System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J. Neurosci., March 22, 2006; 26(12): 3345 - 3356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, N. H. Varvel, B. T. Lamb, and K. Herrup Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models J. Neurosci., January 18, 2006; 26(3): 775 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Stalder, F. Ermini, L. Bondolfi, W. Krenger, G. J. Burbach, T. Deller, J. Coomaraswamy, M. Staufenbiel, R. Landmann, and M. Jucker Invasion of Hematopoietic Cells into the Brain of Amyloid Precursor Protein Transgenic Mice J. Neurosci., November 30, 2005; 25(48): 11125 - 11132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kitazawa, S. Oddo, T. R. Yamasaki, K. N. Green, and F. M. LaFerla Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease J. Neurosci., September 28, 2005; 25(39): 8843 - 8853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, A. Hanke, I. Dewachter, C. Kuiperi, K. O'Banion, T. Klockgether, F. Van Leuven, and G. E. Landreth Acute treatment with the PPAR{gamma} agonist pioglitazone and ibuprofen reduces glial inflammation and A{beta}1-42 levels in APPV717I transgenic mice Brain, June 1, 2005; 128(6): 1442 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sykova, I. Vorisek, T. Antonova, T. Mazel, M. Meyer-Luehmann, M. Jucker, M. Hajek, M. Ort, and J. Bures Changes in extracellular space size and geometry in APP23 transgenic mice: A model of Alzheimer's disease PNAS, January 11, 2005; 102(2): 479 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Fonseca, J. Zhou, M. Botto, and A. J. Tenner Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease J. Neurosci., July 21, 2004; 24(29): 6457 - 6465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schmitz, B. P. F. Rutten, A. Pielen, S. Schafer, O. Wirths, G. Tremp, C. Czech, V. Blanchard, G. Multhaup, P. Rezaie, et al. Hippocampal Neuron Loss Exceeds Amyloid Plaque Load in a Transgenic Mouse Model of Alzheimer's Disease Am. J. Pathol., April 1, 2004; 164(4): 1495 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Burbach, R. Hellweg, C. A. Haas, D. Del Turco, U. Deicke, D. Abramowski, M. Jucker, M. Staufenbiel, and T. Deller Induction of Brain-Derived Neurotrophic Factor in Plaque-Associated Glial Cells of Aged APP23 Transgenic Mice J. Neurosci., March 10, 2004; 24(10): 2421 - 2430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yan, J. Zhang, H. Liu, S. Babu-Khan, R. Vassar, A. L. Biere, M. Citron, and G. Landreth Anti-Inflammatory Drug Therapy Alters {beta}-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease J. Neurosci., August 20, 2003; 23(20): 7504 - 7509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cui, Y. Le, H. Yazawa, W. Gong, and J. M. Wang Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease J. Leukoc. Biol., October 1, 2002; 72(4): 628 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Boncristiano, M. E. Calhoun, P. H. Kelly, M. Pfeifer, L. Bondolfi, M. Stalder, A. L. Phinney, D. Abramowski, C. Sturchler-Pierrat, A. Enz, et al. Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis J. Neurosci., April 15, 2002; 22(8): 3234 - 3243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Jantzen, K. E. Connor, G. DiCarlo, G. L. Wenk, J. L. Wallace, A. M. Rojiani, D. Coppola, D. Morgan, and M. N. Gordon Microglial Activation and beta -Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice J. Neurosci., March 15, 2002; 22(6): 2246 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bondolfi, M. Calhoun, F. Ermini, H. G. Kuhn, K.-H. Wiederhold, L. Walker, M. Staufenbiel, and M. Jucker Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice J. Neurosci., January 15, 2002; 22(2): 515 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. YAZAWA, Z.-X. YU, TAKEDA, Y. LE, W. GONG, V. J. FERRANS, J. J. OPPENHEIM, C. C. H. LI, and J. M. WANG {beta} Amyloid peptide (A{beta}42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages FASEB J, November 1, 2001; 15(13): 2454 - 2462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Bornemann, K.-H. Wiederhold, C. Pauli, F. Ermini, M. Stalder, L. Schnell, B. Sommer, M. Jucker, and M. Staufenbiel A{beta}-Induced Inflammatory Processes in Microglia Cells of APP23 Transgenic Mice Am. J. Pathol., January 1, 2001; 158(1): 63 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Murphy Jr., F. Zhao, L. Yang, and B. Cordell Expression of Macrophage Colony-Stimulating Factor Receptor Is Increased in the A{beta}PPV717F Transgenic Mouse Model of Alzheimer's Disease Am. J. Pathol., September 1, 2000; 157(3): 895 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Calhoun, P. Burgermeister, A. L. Phinney, M. Stalder, M. Tolnay, K.-H. Wiederhold, D. Abramowski, C. Sturchler-Pierrat, B. Sommer, M. Staufenbiel, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid PNAS, November 23, 1999; 96(24): 14088 - 14093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Phinney, T. Deller, M. Stalder, M. E. Calhoun, M. Frotscher, B. Sommer, M. Staufenbiel, and M. Jucker Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice J. Neurosci., October 1, 1999; 19(19): 8552 - 8559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Dickson Microglia in Alzheimer's Disease and Transgenic Models : How Close the Fit? Am. J. Pathol., June 1, 1999; 154(6): 1627 - 1631. [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. Kuo, T. A. Kokjohn, T. G. Beach, L. I. Sue, D. Brune, J. C. Lopez, W. M. Kalback, D. Abramowski, C. Sturchler-Pierrat, M. Staufenbiel, et al. Comparative Analysis of Amyloid-beta Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains J. Biol. Chem., April 13, 2001; 276(16): 12991 - 12998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Tiffany, M. C. Lavigne, Y.-H. Cui, J.-M. Wang, T. L. Leto, J.-L. Gao, and P. M. Murphy Amyloid-beta Induces Chemotaxis and Oxidant Stress by Acting at Formylpeptide Receptor 2, a G Protein-coupled Receptor Expressed in Phagocytes and Brain J. Biol. Chem., June 22, 2001; 276(26): 23645 - 23652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Le, W. Gong, H. L. Tiffany, A. Tumanov, S. Nedospasov, W. Shen, N. M. Dunlop, J.-L. Gao, P. M. Murphy, J. J. Oppenheim, et al. Amyloid {beta}42 Activates a G-Protein-Coupled Chemoattractant Receptor, FPR-Like-1 J. Neurosci., January 15, 2001; 21(2): RC123 - RC123. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
